Financial Advocates Investment Management’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Hold |
15,500
| – | – | ﹤0.01% | 605 |
|
|
2025
Q1 | $121K | Hold |
15,500
| – | – | 0.01% | 690 |
|
|
2024
Q4 | $72.4K | Buy |
15,500
+2,000
| +15% | +$9.34K | ﹤0.01% | 720 |
|
|
2024
Q3 | $72.8K | Buy |
13,500
+2,000
| +17% | +$10.8K | ﹤0.01% | 737 |
|
|
2024
Q2 | $101K | Buy |
11,500
+1,000
| +10% | +$8.82K | 0.01% | 693 |
|
|
2024
Q1 | $123K | Sell |
10,500
-2,000
| -16% | -$23.5K | 0.01% | 726 |
|
|
2023
Q4 | $141K | Buy |
+12,500
| New | +$141K | 0.01% | 696 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 713 |
|
|
2023
Q2 | – | Sell |
-11,500
| Closed | -$74.3K | – | 732 |
|
|
2023
Q1 | $74.3K | Sell |
11,500
-2,151
| -16% | -$13.9K | 0.01% | 710 |
|
|
2022
Q4 | $86.5K | Buy |
+13,651
| New | +$86.5K | 0.01% | 720 |
|
|
2022
Q3 | – | Sell |
-15,167
| Closed | -$134K | – | 781 |
|
|
2022
Q2 | $134K | Hold |
15,167
| – | – | 0.01% | 645 |
|
|
2022
Q1 | $128K | Hold |
15,167
| – | – | 0.01% | 700 |
|
|
2021
Q4 | $155K | Sell |
15,167
-1,500
| -9% | -$15.3K | 0.01% | 736 |
|
|
2021
Q3 | $324K | Sell |
16,667
-3,000
| -15% | -$58.3K | 0.02% | 594 |
|
|
2021
Q2 | $345K | Hold |
19,667
| – | – | 0.02% | 561 |
|
|
2021
Q1 | $234K | Buy |
19,667
+1,500
| +8% | +$17.8K | 0.02% | 664 |
|
|
2020
Q4 | $313K | Hold |
18,167
| – | – | 0.02% | 550 |
|
|
2020
Q3 | $187K | Sell |
18,167
-217,794
| -92% | -$2.24M | 0.02% | 585 |
|
|
2020
Q2 | $1.24M | Sell |
235,961
-17,500
| -7% | -$91.9K | 0.12% | 202 |
|
|
2020
Q1 | $844K | Buy |
253,461
+28,794
| +13% | +$95.9K | 0.12% | 199 |
|
|
2019
Q4 | $1.3M | Hold |
224,667
| – | – | 0.14% | 172 |
|
|
2019
Q3 | $1.33M | Buy |
+224,667
| New | +$1.33M | 0.15% | 154 |
|